Scientific Article
previous document  unige:29787  next document
add to browser collection
Title

The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria

Authors
Ludwig, Ralf J.
Zollner, Thomas Matthias
Ochsendorf, Falk Rudiger
Kaufmann, Roland
Gibbs, B. F.
Published in British Journal of Dermatology. 2003, vol. 148, no. 3, p. 604-606
Keywords AdultAnti-Inflammatory Agents, Non-Steroidal/*therapeutic useChronic DiseaseCyclooxygenase Inhibitors/*therapeutic useFemaleHistamine Release/drug effectsHumansLactones/*therapeutic useMaleMiddle AgedSulfonesUrticaria/*drug therapy
Identifiers
PMID: 12653769
Full text
Citation
(ISO format)
BOEHNCKE, Wolf-Henning et al. The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria. In: British Journal of Dermatology, 2003, vol. 148, n° 3, p. 604-606. https://archive-ouverte.unige.ch/unige:29787

154 hits

0 download

Update

Deposited on : 2013-09-20

Export document
Format :
Citation style :